Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

RUNX2 Regulates Cell Migration in T-Cell Lineage Acute Lymphoblastic Leukemia

Nitesh Devinarayan Sharma, PhD, Christian C. Nickl, Huining Kang, PhD, Wojciech Ornatowski, PhD, Stuart S. Winter, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD, Ksenia Matlawska-Wasowska, PhD

Blood (2019) 134 (Supplement_1): 3947.

https://doi.org/10.1182/blood-2019-129337

Published: 2019

Journal Articles

Comparative Analysis for Effectiveness of Azacitidine Versus Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes in New Mexico: A Single Institution Experience

Khine Z Win, MD, Huining Kang, PhD, Hamzah Munir Alqam, MD, Cecilia Arana-Yi, MD

Blood (2017) 130 (Supplement 1): 5028.

https://doi.org/10.1182/blood.V130.Suppl_1.5028.5028

Published: 2017

Journal Articles

Increased Frequency of Arterial Thromboses Among Patients with Myeloproliferative Neoplasms Living at an Elevation of 5000 Feet Above Sea Level and Beyond

Khine Z Win, MD, Huining Kang, PhD, Pranshu Bansal, MD, Hamzah Munir Alqam, MD, Cecilia Arana-Yi, MD

Blood (2017) 130 (Supplement 1): 5282.

https://doi.org/10.1182/blood.V130.Suppl_1.5282.5282

Published: 2017

Journal Articles

SOCS5 Regulates JAK-STAT Signaling and T-ALL Development

Nitesh Sharma, PhD, Christian Nickl, Huining Kang, PhD, Stuart S. Winter, MD, Judy Cannon, PhD, Ksenia Matlawska-Wasowska, PhD

Blood (2017) 130 (Supplement 1): 370.

https://doi.org/10.1182/blood.V130.Suppl_1.370.370

Published: 2017

Journal Articles

New Insights into Deregulated Gene Expression Pathways in MLL- and AF10 -Rearranged T-Lineage Acute Lymphoblastic Leukemia

Huining Kang, PhD, Nitesh Sharma, PhD, Christian K Nickl, Scott Ness, PhD, Meenakshi Devidas, PhD, Brent L. Wood, MD PhD, Barbara L. Asselin, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Naomi Winick, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Kimberly P. Dunsmore, MD, Richard S. Larson, MD PhD, Stuart S. Winter, MD, Ksenia Matlawska-Wasowska, PhD

Blood (2016) 128 (22): 2906.

https://doi.org/10.1182/blood.V128.22.2906.2906

Published: 2016

Journal Articles

Mixed Lineage Leukemia Rearrangements ( MLL- R ) Are Determinants of High Risk Disease in Homeobox A (HOXA)- deregulated T-Lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Blood (2015) 126 (23): 694.

https://doi.org/10.1182/blood.V126.23.694.694

Published: 2015

Journal Articles

Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like (“ Ph-like ” or “ BCR-ABL1-Like ”) Signature For Therapeutic Targeting and Clinical Intervention

Blood (2013) 122 (21): 826.

https://doi.org/10.1182/blood.V122.21.826.826

Published: 2013

Journal Articles

PDE4B Modulates Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 530.

https://doi.org/10.1182/blood.V120.21.530.530

Published: 2012

Journal Articles

BACH2 Is Required for Pre-B Cell Receptor Checkpoint Control and p53-Dependent Tumor Surveillance

Srividya Swaminathan, B Tech, Huining Kang, PhD, Richard C. Harvey, PhD, Chuanxin Huang, PhD, Maike Buchner, PhD, Zhengshan Chen, MD, PhD, Huimin Geng, Andrew Hall, Kazuhiko Igarashi, PhD, William L. Carroll, MD, Cheryl L. Willman, MD, Ari Melnick, MD, Markus Muschen, MD, PhD

Blood (2012) 120 (21): 1300.

https://doi.org/10.1182/blood.V120.21.1300.1300

Published: 2012

Journal Articles

A BCR-ABL1-Like Gene Expression Profile Confers a Poor Prognosis In Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report From Children's Oncology Group (COG) AALL0232

Blood (2011) 118 (21): 743.

https://doi.org/10.1182/blood.V118.21.743.743

Published: 2011

Journal Articles

Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles (< 90 Days vs. > 90 Days): A Children's Oncology Group Study

Blood (2010) 116 (21): 412.

https://doi.org/10.1182/blood.V116.21.412.412

Published: 2010

Journal Articles

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Cheryl L. Willman, MD, Huining Kang, PhD, Richard C. Harvey, PhD, I-Ming Chen, DVM, MS, Charles Mullighan, MD, James R. Downing, MD, Mary V. Relling, PharmD, Jinghui Zhang, PhD, Daniela Gerhard, PhD, Malcolm Smith, MD, PhD, Kevin K. Dobbin, PhD, Gregory Reaman, MD, Stephen Hunger, MD

Blood (2008) 112 (11): sci-8.

https://doi.org/10.1182/blood.V112.11.sci-8.sci-8

Published: 2008

Journal Articles

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Richard C. Harvey, PhD, George S. Davidson, Xuefei Wang, PhD, Kevin K. Dobbin, PhD, Edward J. Bedrick, PhD, Carla S. Wilson, MD, PhD, Susan R. Atlas, PhD, Huining Kang, PhD, I-Ming Chen, DVM, Stephen P. Hunger, MD, Meenakshi Devidas, PhD, William L. Carroll, MD, Paul Bowman, MD, Bruce Camitta, MD, Gregory Reaman, MD, Cheryl L. Willman, MD

Blood (2007) 110 (11): 1430.

https://doi.org/10.1182/blood.V110.11.1430.1430

Published: 2007

Journal Articles

Expression of Midkine(MDK) and Sensitivity to Anti-Leukemic Drugs in Pediatric Acute Lymphoblastic Leukemia (ALL).

Weihua Zeng, PhD, I-Ming Chen, DVM, Justin Tibbitts, MS, Huining Kang, PhD, Kerem Ar, MS, Susan Atlas, PhD, Cheryl L. Willman, MD

Blood (2007) 110 (11): 1432.

https://doi.org/10.1182/blood.V110.11.1432.1432

Published: 2007

Journal Articles

Molecular Classifiers for Prediction of Minimal Residual Disease (MRD) and Event Free Survival (EFS) Improve Risk Assignment at Diagnosis in Pediatric High-Risk B Precursor Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group Study.

Huining Kang, PhD, Edward J. Bedrick, PhD, I-Ming Chen, DVM, Carla S. Wilson, MD, PhD, Susan R. Atlas, PhD, Richard C. Harvey, PhD, Stephen P. Hunger, MD, Meenakshi Devidas, PhD, Michael J. Borowitz, MD, PhD, Paul Bowman, MD, William L. Carroll, MD, Bruce Camitta, MD, Gregory H. Reaman, MD, Cheryl L. Willman, MD

Blood (2007) 110 (11): 1422.

https://doi.org/10.1182/blood.V110.11.1422.1422

Published: 2007

Journal Articles

Hematopoietic Cell Expression of OPAL1, an Outcome Predictor in Pediatric Acute Lymphoblastic Leukemia.

Weihua Zeng, PhD, I.-Ming Chen, DVM, Yuexian Xu, MS, Jeff Potter, MS, Kerem Ar, MS, Huining Kang, PhD, Cheryl L. Willman, MD

Blood (2005) 106 (11): 1457.

https://doi.org/10.1182/blood.V106.11.1457.1457

Published: 2005

Journal Articles

A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL).

Cheryl L. Willman, MD, Huining Kang, PhD, Jeffrey W. Potter, MS, Richard C. Harvey, PhD, Susan R. Atlas, PhD, Ed Bedrick, PhD, Paul Helman, PhD, Robert L. Veroff, PhD, I.-Ming Chen, DVM, Andrew J. Carroll, PhD, Kerem Ar, MS, Yuexian Xu, MSD, Sharon B. Murphy, MD, Deepa Bhojwani, MD, Naomi Moskowitz, William L. Carroll, MD, Bruce Camitta, MD

Blood (2005) 106 (11): 762.

https://doi.org/10.1182/blood.V106.11.762.762

Published: 2005

Journal Articles

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Naomi P. Moskowitz, MD, Deepa Bhojwani, MD, Huining Kang, PhD, Dong-Joon Min, PhD, Jeffrey Potter, PhD, Richard Harvey, PhD, Nita L. Seibel, MD, Elizabeth Raetz, MD, Harland N. Sather, PhD, Stephen P. Hunger, MD, Cheryl L. Willman, MD, William L. Carroll, MD

Blood (2005) 106 (11): 1449.

https://doi.org/10.1182/blood.V106.11.1449.1449

Published: 2005

NARROW

RUNX2 Regulates Cell Migration in T-Cell Lineage Acute Lymphoblastic Leukemia

Comparative Analysis for Effectiveness of Azacitidine Versus Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes in New Mexico: A Single Institution Experience

Increased Frequency of Arterial Thromboses Among Patients with Myeloproliferative Neoplasms Living at an Elevation of 5000 Feet Above Sea Level and Beyond

SOCS5 Regulates JAK-STAT Signaling and T-ALL Development

New Insights into Deregulated Gene Expression Pathways in MLL- and AF10 -Rearranged T-Lineage Acute Lymphoblastic Leukemia

Mixed Lineage Leukemia Rearrangements ( MLL- R ) Are Determinants of High Risk Disease in Homeobox A (HOXA)- deregulated T-Lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

PDE4B Modulates Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia

BACH2 Is Required for Pre-B Cell Receptor Checkpoint Control and p53-Dependent Tumor Surveillance

A BCR-ABL1-Like Gene Expression Profile Confers a Poor Prognosis In Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report From Children's Oncology Group (COG) AALL0232

Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles (< 90 Days vs. > 90 Days): A Children's Oncology Group Study

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Expression of Midkine(MDK) and Sensitivity to Anti-Leukemic Drugs in Pediatric Acute Lymphoblastic Leukemia (ALL).

Molecular Classifiers for Prediction of Minimal Residual Disease (MRD) and Event Free Survival (EFS) Improve Risk Assignment at Diagnosis in Pediatric High-Risk B Precursor Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group Study.

Hematopoietic Cell Expression of OPAL1, an Outcome Predictor in Pediatric Acute Lymphoblastic Leukemia.

A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL).

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only